Calcifediol
CAS No. 19356-17-3
Calcifediol( 25-Hydroxyvitamin D3 | 25-Hydroxycholecalciferol )
Catalog No. M13032 CAS No. 19356-17-3
The major circulating metabolite of vitamin D3.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 103 | In Stock |
|
| 2MG | 57 | In Stock |
|
| 5MG | 85 | In Stock |
|
| 10MG | 140 | In Stock |
|
| 25MG | 282 | In Stock |
|
| 50MG | 445 | In Stock |
|
| 100MG | 685 | In Stock |
|
| 200MG | 918 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCalcifediol
-
NoteResearch use only, not for human use.
-
Brief DescriptionThe major circulating metabolite of vitamin D3.
-
DescriptionThe major circulating metabolite of vitamin D3; it is produced in the liver and is the best indicator of the body's vitamin D stores; it is effective in the treatment of RICKETS and OSTEOMALACIA, both in azotemic and non-azotemic patients; also has mineralizing properties.Osteoporosis Approved.
-
In Vitro——
-
In Vivo——
-
Synonyms25-Hydroxyvitamin D3 | 25-Hydroxycholecalciferol
-
PathwayMetabolic Enzyme/Protease
-
TargetVitamin
-
RecptorOthers
-
Research AreaMetabolic Disease
-
IndicationOsteoporosis
Chemical Information
-
CAS Number19356-17-3
-
Formula Weight400.6371
-
Molecular FormulaC27H44O2
-
Purity>98% (HPLC)
-
Solubility10 mM in DMSO
-
SMILES[H][C@]([C@]1(C)CCC/2)(CC[C@]1([H])[C@H](C)CCCC(C)(O)C)C2=C\C=C3C[C@@H](O)CCC\3=C
-
Chemical Name1H-Indene-1-pentanol, 4-[(2Z)-2-[(5S)-5-hydroxy-2-methylenecyclohexylidene]ethylidene]octahydro-α,α,ε,7a-tetramethyl-, hydrate (1:1), (εR,1R,3aS,4E,7aR)-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Vitamin?E?Acetate
A natural tocopherol and one of the most potent antioxidant tocopherols. It exhibits antioxidant activity by virtue of the phenolic hydrogen on the 2H-1-benzopyran-6-ol nucleus.
-
Coumetarol
Coumetarol (Dicumoxane) is a vitamin K antagonist and an oral anticoagulant that can be used to study arterial thrombotic occlusion.
-
MeTC7
MeTC7 is a vitamin D receptor (VDR) antagonist with antitumor activity that inhibits PD-L1 and may inhibit the growth of xenografts and transgenic tumors in vivo.
Cart
sales@molnova.com